Abstract: A flow cell for a microfluidic device can include a chamber, first microfluidic entry and exit channels, second microfluidic entry and exit channels, a first electrode, and a second electrode. A microfluidic device can include a microfluidic channel, a laser to excite fluorescent material, and a detector to detect fluorescence emission. Methods of merging a droplet from an emulsion in to a second stream of fluid and of detecting a content of a droplet in a stream are further disclosed.
Abstract: The present invention provides novel antibodies to human CXCR4 with high affinity to the target and the ability to act potently as antagonists. The antibodies disclosed herein bind to a diverse range of epitopes.
Type:
Grant
Filed:
March 18, 2014
Date of Patent:
February 16, 2016
Assignee:
SDIX, LLC
Inventors:
Ross S. Chambers, Michael C. Brown, Dale V. Onisk, L. Joe Stafford, Fenglin Yin
Abstract: The present invention provides novel antibodies to human CXCR4 with high affinity to the target and the ability to act potently as antagonists. The antibodies disclosed herein bind to a diverse range of epitopes.
Type:
Application
Filed:
March 18, 2014
Publication date:
September 25, 2014
Applicant:
SDIX, LLC
Inventors:
Ross S. CHAMBERS, Michael C. BROWN, Dale V. ONISK, L. Joe STAFFORD, Fenglin YIN